A phase I/II trial of induction chemotherapy plus gefitinib (Iressa) followed by concurrent chemotherapy, radiation therapy, and gefitinib (Iressa) for patients with locally advanced squamous carcinoma of the head and neck

Trial Profile

A phase I/II trial of induction chemotherapy plus gefitinib (Iressa) followed by concurrent chemotherapy, radiation therapy, and gefitinib (Iressa) for patients with locally advanced squamous carcinoma of the head and neck

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Nov 2013

At a glance

  • Drugs Carboplatin; Docetaxel; Fluorouracil; Gefitinib
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2007 New trial centre added.
    • 22 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top